Bristol Myers backs a European VC's record-setting biotech venture fund, which tops out at $600M
A European biotech venture group with a yen for transatlantic deals will face whatever is coming on the investment side of the business with a new fund that claims boasting rights as the largest life sciences fund ever raised on the continent.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,500+ biopharma pros reading Endpoints daily — and it's free.